Related Experiment Video
Updated: Apr 1, 2026
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Increased Expression of Matrix Metalloproteinase-9 in Patients with Temporal Lobe Epilepsy
Goksemin Acar1, Gamze Tanriover, Feridun Acar
1Pamukkale University, School of Medicine, Department of Neurology, Denizli, Turkey.
Aim:
The molecular mechanism of epileptogenesis in temporal lobe epilepsy is still unclear. Experimental studies have suggested that matrix metalloproteinases have important roles in this process, but human studies are limited. The aim of this study was to assess the expression of MMP-9, MMP-2 and their tissue inhibitors (TIMP-1 and TIMP-2) in patients with temporal lobe epilepsy with hippocampal sclerosis (TLE-HS).
Material And Methods:
The tissue samples from temporal neocortex and hippocampus were obtained from patients with temporal lobe epilepsy with hippocampal sclerosis who had undergone anterior temporal lobectomy for recurrent medically resistant seizures. Immunohistochemical methods were used to determine the expression of MMP-9, MMP-2 and their tissue inhibitors. Tissue samples were also analyzed with transmission electron microscopy.
Results:
The immunoreactivity for MMP-9 both in hippocampal and temporal neocortical neurons was stronger than that of MMP-2. Additionally, there was a mild reaction for its tissue inhibitor TIMP-1 as with TIMP-2. The TEM analysis of the hippocampus revealed that there was apparent ultra-structural damage on the pericarya and neuropil of some neurons. There was obvious damage in the mitochondria and the nuclear membrane.
Conclusion:
The preliminary results of this study revealed that MMP-9 may have a role in patients with drug resistant TLE-HS.
Insights
Matrix metalloproteinase-9 (MMP-9) may play a role in drug-resistant temporal lobe epilepsy with hippocampal sclerosis (TLE-HS). This study found higher MMP-9 expression and neuronal damage in TLE-HS patients.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- The molecular mechanisms of epileptogenesis in temporal lobe epilepsy (TLE) remain incompletely understood.
- Matrix metalloproteinases (MMPs) are implicated in epileptogenesis, but human data are scarce.
- Temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) is a common form of drug-resistant epilepsy.
Purpose of the Study:
- To investigate the expression of MMP-9, MMP-2, and their inhibitors TIMP-1 and TIMP-2 in patients with TLE-HS.
- To correlate MMP expression with ultrastructural neuronal damage in TLE-HS.
Main Methods:
- Immunohistochemistry was used to quantify MMP-9, MMP-2, TIMP-1, and TIMP-2 expression in temporal neocortex and hippocampus samples from TLE-HS patients.
- Transmission electron microscopy (TEM) was employed to assess neuronal ultrastructure.
Main Results:
- Immunoreactivity for MMP-9 was significantly higher than for MMP-2 in both hippocampal and neocortical neurons.
- Mild expression of TIMP-1 and TIMP-2 was observed.
- TEM revealed ultrastructural damage in neuronal pericarya and neuropil, including mitochondria and nuclear membranes.
Conclusions:
- Preliminary findings suggest MMP-9 may contribute to the pathophysiology of drug-resistant TLE-HS.
- Elevated MMP-9 expression correlates with observed neuronal damage in TLE-HS.
